Genadyne Biotechnologies
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 Midland Ave, Hicksville, New York, 11...Phone Number
(516) 487-8787Website
www.genadyne.comRevenue
$144.4 MillionIndustry
About Genadyne Biotechnologies
Genadyne Biotechnologies Org Chart
Is Genadyne Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Genadyne Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Genadyne Biotechnologies recently announced quarterly report
Check if Genadyne Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Genadyne Biotechnologies is spiking on competitors!
Funding: Get notified immidiatlly once Genadyne Biotechnologies has new funding data
Congratulate Masked Content for being promoted to Masked Content at Genadyne Biotechnologies
Product Launch: Get notified when Genadyne Biotechnologies launches new products
Click to see if Genadyne Biotechnologies had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Genadyne Biotechnologies
Compare insights from companies similar to Genadyne Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Genadyne Biotechnologies
Company Profile Activity
Activity Insights
Genadyne Biotechnologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genadyne Biotechnologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genadyne Biotechnologies.
Genadyne Biotechnologies financials insights
Gather financial insights about Genadyne Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$350K
Genadyne Biotechnologies Tech Stack
A closer look at the technologies used by Genadyne Biotechnologies
Most Recent Scoops
Genadyne Biotechnologies News & Media
InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy SystemsJZZ Technologies, Inc. Acquisition of Company with Five Therapeutics
West Palm Beach, Florida--(Newsfile Corp. - December 1, 2021) - As announced via press release on November 16, 2021, JZZ Technologies, Inc. (OTC Pink: JZZI) signed an LOI with NutraEdge Bioscience Corp. dated November 10, 2021. This press release supplements the release of November 16, 2021. JZZ Technologies, Inc. intends to continue its due diligence on the target acquisition, a US Biotechnology Company that has a range of natural healthcare formulations assigned to it, which...Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti ...
SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Dakshidin Corp (OTC PINK:DKSC) CEO Chris Haigh and Giles Tilley, Managing Director of GenBio Inc. an early-stage Biotechnology Company joined Stock Day host Everett Jolly for an interview.GenBio, Inc. Discusses Entering the 191 Billion Dollar Anti-Inflammatory Market, Potential of Their Research, Crowdfunding Offering, and Their Strategic Partnership with Dakshidin Corp. on The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - May 17, 2021) - The Stock Day Podcast welcomed GenBio, Inc. and Dakshidin Corp (OTC Pink: DKSC) ("the Company"). Giles Tilley, Managing Director of GenBio Inc. an early-stage Biotechnology Company with unrivaled (and possibly unique) research expertise based on an unexpected yet vitally important medical research breakthrough - described by the US scientific team as "never seen before", and Dakshidin Corp. CEO, Chris Haigh, joined Stock Day host Everett Jolly.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genadyne Biotechnologies
Genadyne specializes in innovative healthcare solutions focused on accelerated wound healing. Their product range includes various wound care devices such as pumps, dressing kits, and canisters designed for patient safety and comfort. The company aims to support clinicians and caregivers in achieving positive clinical outcomes while enhancing patie... Read More